The anti-inflammatory regulation of ATP-induced interleukin-1β release by short-chain fatty acids acetate, butyrate, propionate
dc.contributor.advisor | Grau, Veronika | |
dc.contributor.advisor | Richter, Katrin | |
dc.contributor.advisor | Pullamsetti, Soni Savei | |
dc.contributor.author | Herbolsheimer, Anna Isabel | |
dc.date.accessioned | 2024-07-08T09:52:57Z | |
dc.date.available | 2024-07-08T09:52:57Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Interleukin-1β (IL-1β) is a pro-inflammatory cytokine, that is mainly secreted by activated monocytes and macrophages. When IL-1β is released, numerous effects are seen, such as the release of cytokines and chemokines which additionally stimulate the bone marrow. A dysregulation of the IL-1β secretion can lead to systemic diseases. Therefore, the release of IL-1β needs to be strictly regulated. The first stimulus by a pathogen-associated molecular pattern (PAMP) such as lipopolysaccharide (LPS), results in the production of the precursor protein pro-interleukin-1β (pro-IL-1β) and the proteins that form the NLRP3-inflammasome. The P2X7 receptor is activated via the second stimulus being for example ATP from damaged cells, which leads to the assembly of the NLRP3-inflammasome and consecutive release of mature IL-1β. In this thesis, experiments were performed on human peripheral blood mononuclear cells (hPBMCs), mouse peripheral blood mononuclear cells (mPBMCs) and mouse bone marrow-derived macrophages (mouse BMDMs). BzATP acted as a potent second signal in hPBMCs, however, contrary to published literature, ATP has seen to be a more potent P2X7 agonist in mPBMCs and mouse BMDMs. Furthermore, not only the P2X7 receptor but also the P2X4 receptor was shown to play a role in the BzATP- or ATP-dependent release of IL-1β in hPBMCs and mouse BMDMs. Recent studies show, that the release of ATP-induced IL-1β can be inhibited via a cholinergic mechanism. In this present work, the cholinergic mechanism is seen to be induced by synthetic FFA agonists and the natural FFA agonists being short-chain fatty acids (SCFAs), in all cells tested. Specifically, the FFA2 has shown to be necessary for the inhibition of the secretion of ATP-dependent IL-1β. This was seen by performing experiments on FFA2 gene-deficient mPBMCs. The exact signal transduction of the anti-inflammatory role shown by SCFAs is in need of further research. Additionally, there is a high potential seen in SCFAs as a therapeutic approach against inflammatory diseases. Therefore, further research in this field is of importance. | |
dc.identifier.uri | https://jlupub.ub.uni-giessen.de/handle/jlupub/19298 | |
dc.identifier.uri | https://doi.org/10.22029/jlupub-18659 | |
dc.language.iso | en | |
dc.rights | In Copyright | * |
dc.rights.uri | http://rightsstatements.org/page/InC/1.0/ | * |
dc.title | The anti-inflammatory regulation of ATP-induced interleukin-1β release by short-chain fatty acids acetate, butyrate, propionate | |
dc.type | doctoralThesis | |
dcterms.dateAccepted | 2024-06-24 | |
local.affiliation | FB 11 - Medizin | |
thesis.level | thesis.doctoral |
Dateien
Originalbündel
1 - 1 von 1
Lade...
- Name:
- HerbolsheimerAnnaIsabel-2024-06-24.pdf
- Größe:
- 2.64 MB
- Format:
- Adobe Portable Document Format
Lizenzbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- license.txt
- Größe:
- 7.58 KB
- Format:
- Item-specific license agreed upon to submission
- Beschreibung: